A Trial of an Augmented Exercise Program in the Prevention of Deconditioning Among Survivors of Severe Burns (AEP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01105637|
Recruitment Status : Completed
First Posted : April 16, 2010
Last Update Posted : June 23, 2016
Burn injuries can affect how well you are able to perform daily activities. The reason this study is being done is to find out if aerobic exercise helps burn patients recover function, strength and stamina.
Participants will come to Johns Hopkins Bayview Medical Center, Burn Rehabilitation Gym for treadmill exercise sessions 3 days per week for 12 weeks. Participants will be tested for strength and stamina before the start of the 12 week program, at the end of the 12 week program, as well as 6 months, 1 year and 2 years after the end of the 12 week program.
Patients who recently suffered a burn injury and who were discharged from the hospital in the past six months may be eligible to participate.
|Condition or disease||Intervention/treatment||Phase|
|Deconditioning Among Survivors of Severe Burns||Behavioral: Augmented Exercise Program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Trial of an Augmented Exercise Program in the Prevention of Deconditioning Among Survivors of Severe Burns|
|Study Start Date :||July 2007|
|Actual Primary Completion Date :||January 2012|
|Actual Study Completion Date :||January 2012|
Behavioral: Augmented Exercise Program
12 week (3 x per week) exercise prescription
- Maximal Oxygen Consumption (VO2 max) [ Time Frame: 2 Years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01105637
|United States, Maryland|
|Johns Hopkins Bayview Medical Center|
|Baltimore, Maryland, United States, 21224|
|Principal Investigator:||Barbara J de Lateur, MD||Johns Hopkins Univeristy School of Medicine|